Previous 10 | Next 10 |
WAYNE, Pa., July 06, 2021 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX) today announced that new data from real-world clinical studies of the UroLift ® System for men with benign prostatic hyperplasia (BPH) will be presented at the 36 th European Association of Urology (...
WAYNE, Pa., June 28, 2021 (GLOBE NEWSWIRE) -- Today, Teleflex Incorporated (NYSE:TFX), a leading global provider for healthcare supplies and services, announced it has completed the previously announced divestiture of a significant portion of its Respiratory business to Medline Industries, ...
WAYNE, Pa., June 16, 2021 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) today announced results of a new survey showing that men with urinary symptoms common with an enlarged prostate, also known as benign prostatic hyperplasia or BPH, may anticipate and plan for their urgent and fr...
WAYNE, Pa., June 07, 2021 (GLOBE NEWSWIRE) -- Thomas Powell, Executive Vice President and Chief Financial Officer, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the Raymond James 2021 Human Health Innovation Conference on Monday, June 21, 2021 at 8:40 a.m. (ET). A live a...
#Trading Teleflex (NYSE: TFX) or any other #stock for that matter requires a degree of #disciple that not every #investor has. Even those that have discipline often fail to adhere to those disciplines sometimes, and this can cause problems, but hopefully the guides below will help...
Teleflex started 2021 on a solid note and raised the full year guidance nominally. Operating momentum is to be applauded, although shares have seen a big rally from $320 to $400 since the dip in autumn. I like the operational performance as my investment thesis remains unchanged a...
Some people say that #timing does not matter, but it does. If you were to #buyandhold Teleflex (NYSE: TFX) at a high, see it fall, and not be able to buy more on the dip like the big boys can, that would be troubling. Over time, Stock Traders Daily has found a way to...
Teleflex (TFX) to sell a significant portion of its Respiratory business to Medline Industries for $286M in cash, reduced by $12M in working capital not transferring to Medline.The product lines to be divested will include oxygen and aerosol therapy, active humidification, non-invasive ventil...
Total consideration is $286 million, reduced by $12 million of working capital to be retained by Teleflex Assets to be divested generated $139M in 2020 revenue, with 2021 growth expected to be approximately flat 2021 headwinds are estimated at $28-32 million in revenue and $0....
The following slide deck was published by Teleflex Incorporated in conjunction with this event. For further details see: Teleflex Incorporated (TFX) Investor Presentation - Slideshow
News, Short Squeeze, Breakout and More Instantly...
WAYNE, Pa., July 29, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced it was awarded two group purchasing agreements with Premier, Inc. Effective July 1, 2024, the Premier National Hemostasis Products and SURPASS® ...
WAYNE, Pa., July 24, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced the establishment of the Teleflex Center for Antimicrobial Protection (TCAP) as a strategic branch of its Vascular Access business unit led by Chuck ...
WAYNE, Pa., July 18, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX) will host a conference call to discuss its second quarter financial results and provide an operational update at 8:00 a.m. Eastern Time on Thursday, August 1, 2024. To participate in the conference call, ple...